Skip to content

Study on optimization and evaluation of acupuncture treatment plan for Long COVID

Study on optimization and evaluation of acupuncture treatment plan for Long COVID

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078558
Enrollment
Unknown
Registered
2023-12-12
Start date
2023-02-09
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

long COVID

Interventions

Fatigue acupuncture group:acupuncture
Fatigue warm acupuncture group:warm acupuncture
Fatigue Du moxibustion group:Du moxibustion
Fatigue waiting group:no intervention
Insomnia acupuncture group:acupouncture
Insomnia warm acupuncture group:warm acupuncture
Insomnia Du moxibustion group:Du moxibustion
Insomnia waiting group:no intervention
Low back pain acupuncture group:acupuncture
Low back pain Du moxibustion group:Du moxibustion
Low back pain cupping group:cupping
Low back pain waiting group:no intervention

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Previously met the diagnostic criteria for COVID-19 infection; 2.Fatigue Severity Scale (FSS ) score = 36 or Insomnia Severity Index ( ISI ) score = 8 or patients with low back pain or pain than before, and VAS score = 4; 3.The symptoms of fatigue, insomnia and low back pain appeared after the novel coronavirus infection, which were directly related to the novel coronavirus infection and met the diagnostic criteria of ' Long COVID-19 '; 4.Age 18-80 years old ; 5.The patient is conscious, emotionally stable, and can cooperate with treatment; 6.Informed and agreed to this study, signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of neuropsychiatric disorders or audio-visual disorders that lead to communication difficulties; 2.Pregnant and lactating women; 3.Pneumonia patients diagnosed with severe and critical novel coronavirus infection or those who need mechanical ventilation or systemic anti-hormone therapy; 4.Patients with previous or current diseases, which may affect the patient to participate in the trial or affect the outcome of the study, including:malignant diseases, autoimmune diseases, severe liver and kidney diseases; diseases that seriously affect the immune system (e.g. human immunodeficiency virus (HIV) infection), or blood system diseases, or splenectomy, organ transplantation, etc., and blood infectious diseases; 5.Patients who are not suitable for acupuncture and moxibustion treatment: allergic to alcohol, moxibustion, ginger, needlesand so on; skin damage at the acupuncture site; fear of acupuncture. moxibustion and so on.

Design outcomes

Primary

MeasureTime frame
Fatigue Severity Scale;Insomnia Severity Index;Oswestry Disability Index;visual analogue scale;

Secondary

MeasureTime frame
Fatigue effective improvement rate;Fatigue assessment instrument;Insomnia effective improvement rate;Self-rating depression scale;Self-Rating Anxiety Scale;Insomnia PRO scale;Low back pain effective improvement rate;Abdominal and back muscle isometric endurance test;Quebec Back Pain Disability Scale;Low back pain PRO scale;Modified WHO disease progression scale;SF-36;survival;

Countries

China

Contacts

Public ContactXiaonong Fan

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine.

fanxiaonong@163.com+86 139 0208 0823

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026